Filing of Application for reclassification with stock exchanges
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharmaceutical Industries has submitted an application to NSE and BSE seeking no-objection/approval for reclassifying an entity from the 'Promoter Group' category to the 'Public' category under SEBI Regulation 31A. This follows earlier intimations dated 14 May 2026 and 22 May 2026, indicating this is part of an ongoing process. The reclassification means the entity will no longer be treated as part of the controlling shareholder group and will be classified as a regular public shareholder. The filing was made on 26 May 2026 by Company Secretary Anoop Deshpande.
This reclassification reduces the listed promoter group's holding, which may marginally impact the perceived promoter stake of the company. It does not involve actual share transfer but changes the regulatory classification of the shareholder.